CD33 Primary Antibodies

CD33 Novocastra

急性骨髄性白血病: NCL-L-CD33 を用いた CD33 抗原の免疫組織化学染色。悪性細胞 の細胞質と細胞膜が強く染色されている。パラフィン切片。
急性骨髄性白血病: NCL-L-CD33 を用いた CD33 抗原の免疫組織化学染色。悪性細胞 の細胞質と細胞膜が強く染色されている。パラフィン切片。

Antigen Background

CD33 antigen is reported to appear on myelomonocytic precursor cells after CD34 antigen expression. It then continues to be expressed on both the myeloid and monocyte lineages, although it is reported to be absent on granulocytes. It has been reported that expression of CD33 is restricted to monocytes, premyelocytes, myeloid blasts, some acute undifferentiated leukemias and acute lymphoblastic leukemias.

 


loading...

CLONE: PWS44

製品の注文はこちら

商品番号 商品名 Configuration Use Datasheet MSDS 数量
PA0555 7ml CD33 Bond RTU Primary Bond ready to use reagent P(HIER) Info MSDS 1
CD33-L 1ml NCL-L-CD33 Liquid Concentrated Monoclonal Antibody P(HIER) Info MSDS 1
CD33-L-S 0.1ml NCL-L-CD33 Liquid Concentrated Monoclonal Antibody P(HIER) Info MSDS 1
CD33-L-CE-S 0.1ml NCL-L-CD33 Liquid Concentrated Monoclonal Antibody P(HIER) Info MSDS 1
CD33-L-CE 1ml NCL-L-CD33 Liquid Concentrated Monoclonal Antibody P(HIER) Info MSDS 1